Our mantra for Sponsors and CRO’s is:
"To ensure the success of your trial - It’s our job to remove the variables before the trial starts."
To enable this the Fusion Business Enablers include:
Fusion Marketing
Our specialist Marketing Team utilises social media, radio, public relations and access to our general practice and specialist network.
Fusion Database
More than 10,000 participants are on our active data base ensuring recruitment targets are met.
Fusion Participant Engagement and Scheduling Team
Enables and achieves a high volume of registrations and enrolments for trials; Schedules all participant trial appointments.
Fusion Study Team
Involved from start-up through to close out; Responsible for trial management and coordination; Provide data and laboratory services; Guarantee quality assurance.
Medical and Nursing Team
An experienced team of Principal Investigators, doctors and nurses undertaking consent, screening, assessment, dosing, review and continuity of care.
Business Development Team
Development of proposals, budgets and contracts to meet sponsors and CRO needs; Liaison and relationship management with general practice and specialists.
Recent Fusion trials
Vaccinations
-
Pneumococcal
-
Norovirus
-
RSV
-
COVID-19
-
Influenza
-
Combination Vaccines (COVID-19/influenza)
Medical Conditions and Disease
-
Mental Health
-
Sleep Disorders
-
Cardiac
-
Obesity and metabolic disorders
-
Diabetes
-
Dermatology
Are you interested in partnering with Fusion Clinical Research to conduct a clinical trial?
Our Advantage
Fusion Clinical Research is based at Norwood, in Adelaide SA. Our experienced team comprises doctors, nurses, scientists and technicians who are practised in client services and patient care; trial start-up activities and trial execution with access to a broad patient population through an extensive GP and specialist network.
Further, Australia is home to some of the world's best researchers and health professionals and boasts a world-class research infrastructure, a stable socio-political environment, and high standards that ensure confidence in the scientific conclusions reached by clinical trials conducted in Australia.
Australia has an efficient regulatory pathway for clinical trials. Under the Clinical Trials Notification (CTN) scheme administered by the Therapeutic Goods Administration (TGA), research proposals are submitted directly to Australian Human Research Ethics Committees (HRECs) which assume the primary review responsibility for ethical and scientific review. The usual review cycle takes only 4 to 8 weeks.
Our services are eligible for the Australian R&D Tax Incentive scheme. This scheme allows eligible companies to claim up to a 43.5%* rebate on qualifying R&D spend.
Above all, the new system provides a globally competitive tax incentive for conducting R&D activities in Australia. For more information about the R&D Tax Incentive, Fusion Clinical Research can provide details of experience advisors.
*Please note this rebate percentage is subject to change.